Antrocinol-mediated downregulation of ATG5 induces autophagy-dependent cell death and activates the unfolded protein response through PERK/CHOP signaling in lenvatinib-resistant hepatocellular carcinoma cells
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.178115 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Shiue-Wei Lai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei City 1149…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Autophagy, Unfolded Protein Response. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Tri-Service General Hospital, National Science Council, National Science and Technology Council.
Abstract (Originalsprache)
BACKGROUND: This study seeks to provide preclinical evidence demonstrating the potential of Antrocinol, a derivative of antrocin derived from the active compound of Antrodia cinnamomea, as a promising small-molecule drug candidate for overcoming drug-resistant hepatocellular carcinoma (HCC). METHODS: We developed Lenvatinib-resistant Huh-7 and HepG2 cell lines (Huh-7/LR, HepG2/LR) to evaluate their viability and apoptotic response to Antrocinol. Autophagy-dependent cell death was assessed in Huh-7/LR cells using Z-VAD-FMK and shATG5 transfection. Key UPR pathway markers were analyzed via Western blot and qRT-PCR. An orthotopic hepatocellular carcinoma mouse model was used to confirm Antrocinol's in vivo effects. RESULTS: Antrocinol reduced Huh-7/LR cell viability and increased apoptosis, with dose-dependent activation of caspase-3, -8, and -9. Z-VAD-FMK inhibited caspase activity but did not prevent apoptosis, indicating the presence of additional cell death mechanisms. Western blot and qRT-PCR confirmed UPR activation via upregulation of BiP/GRP78, PERK, eIF2α, ATF4, and CHOP. ATG5 knockdown abolished Antrocinol-induced cell death, confirming the role of autophagy. Combined with Lenvatinib, Antrocinol synergistically enhanced autophagy and apoptosis, inhibiting tumor growth in vitro and in vivo. CONCLUSION: This study provides the first evidence that Antrocinol, a novel hydroxylated derivative of antrocin, synergises with Lenvatinib to exert anti-proliferative effects on Lenvatinib-resistant HCC cells. Our results indicate that Antrocinol may enhance chemosensitivity in HCC by activating the unfolded protein response (UPR) pathway, specifically through the PERK/CHOP axis, and promoting autophagy-dependent cell death. These findings suggest that autophagy acts as a tumor-suppressive mechanism in HCC, with potential therapeutic implications for overcoming drug resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei City 11490, Taiwan; Department of Internal Medicine, Tri-Service General Hospit…
- Division of Colon and Rectal Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei City 11490, Taiwan.
- Department of Dentistry, Taipei Medical University-Shuang Ho Hospital, New Taipei City, 23561, Taiwan; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei City, 110, Taiwan.
- Department of Surgery, Division of Thoracic Surgery, Taipei Medical University Shuang-Ho Hospital, New Taipei City 23561, Taiwan.
- Department of Medical Research & Education, Taipei Medical University - Shuang Ho Hospital, New Taipei City 23561, Taiwan.
- Department of Applied Science, National Taitung University, Taitung, 95092, Taiwan.
Förderung
- Tri-Service General Hospital
- National Science Council
- National Science and Technology Council
Zitieren
APA
Lai, S. W., Cheng, Y. C., Hsieh, M. S., Kuo, K. T., Yadav, V. K., Tzeng, Y. M., Yeh, C. T., & Tsai, T. Y. (2025). Antrocinol-mediated downregulation of ATG5 induces autophagy-dependent cell death and activates the unfolded protein response through PERK/CHOP signaling in lenvatinib-resistant hepatocellular carcinoma cells. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178115
Vancouver
Lai SW, Cheng YC, Hsieh MS, Kuo KT, Yadav VK, Tzeng YM, et al. Antrocinol-mediated downregulation of ATG5 induces autophagy-dependent cell death and activates the unfolded protein response through PERK/CHOP signaling in lenvatinib-resistant hepatocellular carcinoma cells. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178115
BibTeX
@article{Lai2025,
author = {Lai, Shiue-Wei and Cheng, Yi-Chiao and Hsieh, Ming-Shou and Kuo, Kuang-Tai and Yadav, Vijesh Kumar and Tzeng, Yew-Min and Yeh, Chi-Tai and Tsai, Tung-Yao},
title = {Antrocinol-mediated downregulation of ATG5 induces autophagy-dependent cell death and activates the unfolded protein response through PERK/CHOP signaling in lenvatinib-resistant hepatocellular carcinoma cells},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.178115}
}
EUVIMED